Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Cash & Current Investments (2018 - 2019)

Historic Cash & Current Investments for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q3 2019 value amounting to $9.7 million.

  • DiaMedica Therapeutics' Cash & Current Investments rose 14994.87% to $9.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $9.7 million, marking a year-over-year increase of 14994.87%. This contributed to the annual value of $16.8 million for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q3 2019, DiaMedica Therapeutics' Cash & Current Investments is $9.7 million, which was up 14994.87% from $11.0 million recorded in Q2 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Cash & Current Investments peaked at $16.8 million during Q4 2018, and registered a low of $3.9 million during Q3 2018.